Patheon, Platform board repricing train from US
Patheon, the US pharmaceutical contract manufacturing firm, held a lender call on Monday for a repricing of its €465m cov-lite term loan, as did fellow US company Platform Specialty Products for its own €575m term loan.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts